176 related articles for article (PubMed ID: 28457664)
1. In Vivo Delivery and Therapeutic Effects of a MicroRNA on Colorectal Liver Metastases.
Oshima G; Guo N; He C; Stack ME; Poon C; Uppal A; Wightman SC; Parekh A; Skowron KB; Posner MC; Lin W; Khodarev NN; Weichselbaum RR
Mol Ther; 2017 Jul; 25(7):1588-1595. PubMed ID: 28457664
[TBL] [Abstract][Full Text] [Related]
2. Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
Lu M; Zessin AS; Glover W; Hsu DS
PLoS One; 2017; 12(1):e0169439. PubMed ID: 28060954
[TBL] [Abstract][Full Text] [Related]
3. High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer.
Rasmussen MH; Jensen NF; Tarpgaard LS; Qvortrup C; Rømer MU; Stenvang J; Hansen TP; Christensen LL; Lindebjerg J; Hansen F; Jensen BV; Hansen TF; Pfeiffer P; Brünner N; Ørntoft TF; Andersen CL
Mol Oncol; 2013 Jun; 7(3):637-46. PubMed ID: 23506979
[TBL] [Abstract][Full Text] [Related]
4. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
5. Systemic miRNA delivery by nontoxic nanoscale coordination polymers limits epithelial-to-mesenchymal transition and suppresses liver metastases of colorectal cancer.
Chan C; Guo N; Duan X; Han W; Xue L; Bryan D; Wightman SC; Khodarev NN; Weichselbaum RR; Lin W
Biomaterials; 2019 Jul; 210():94-104. PubMed ID: 31060867
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
[No Abstract] [Full Text] [Related]
7. EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer.
Xiao Z; Liu Y; Li Q; Liu Q; Liu Y; Luo Y; Wei S
Cancer Chemother Pharmacol; 2021 Dec; 88(6):1021-1031. PubMed ID: 34599680
[TBL] [Abstract][Full Text] [Related]
8. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
[TBL] [Abstract][Full Text] [Related]
9. Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapy.
Liu D; Poon C; Lu K; He C; Lin W
Nat Commun; 2014 Jun; 5():4182. PubMed ID: 24964370
[TBL] [Abstract][Full Text] [Related]
10. Decreased miR-340 expression in bone marrow is associated with liver metastasis of colorectal cancer.
Takeyama H; Yamamoto H; Yamashita S; Wu X; Takahashi H; Nishimura J; Haraguchi N; Miyake Y; Suzuki R; Murata K; Ohue M; Kato T; Takemasa I; Mizushima T; Ishii H; Mimori K; Doki Y; Mori M
Mol Cancer Ther; 2014 Apr; 13(4):976-85. PubMed ID: 24448820
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1.
Ji D; Chen Z; Li M; Zhan T; Yao Y; Zhang Z; Xi J; Yan L; Gu J
Mol Cancer; 2014 Apr; 13():86. PubMed ID: 24755295
[TBL] [Abstract][Full Text] [Related]
12. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
[TBL] [Abstract][Full Text] [Related]
13. Prognostic microRNA expression signature from examination of colorectal primary and metastatic tumors.
Ellermeier C; Vang S; Cleveland K; Durand W; Resnick MB; Brodsky AS
Anticancer Res; 2014 Aug; 34(8):3957-67. PubMed ID: 25075017
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer.
Zhang Y; Geng L; Talmon G; Wang J
J Biol Chem; 2015 Mar; 290(10):6215-25. PubMed ID: 25616665
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor functions of miR-133a in colorectal cancer.
Dong Y; Zhao J; Wu CW; Zhang L; Liu X; Kang W; Leung WW; Zhang N; Chan FK; Sung JJ; Ng SS; Yu J
Mol Cancer Res; 2013 Sep; 11(9):1051-60. PubMed ID: 23723074
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
[TBL] [Abstract][Full Text] [Related]
17. miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses.
Jiang T; Ye L; Han Z; Liu Y; Yang Y; Peng Z; Fan J
J Exp Clin Cancer Res; 2017 Sep; 36(1):131. PubMed ID: 28938919
[TBL] [Abstract][Full Text] [Related]
18. miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells.
Rasmussen MH; Lyskjær I; Jersie-Christensen RR; Tarpgaard LS; Primdal-Bengtson B; Nielsen MM; Pedersen JS; Hansen TP; Hansen F; Olsen JV; Pfeiffer P; Ørntoft TF; Andersen CL
Nat Commun; 2016 Aug; 7():12436. PubMed ID: 27526785
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.
Wang K; Liu L; Zhang T; Zhu YL; Qiu F; Wu XG; Wang XL; Hu FQ; Huang J
Int J Nanomedicine; 2011; 6():3207-18. PubMed ID: 22238509
[TBL] [Abstract][Full Text] [Related]
20. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
